Characterization of the activity of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt in hydroxyl radical elimination

被引:0
|
作者
Tomita, T [1 ]
Kashima, M [1 ]
Tsujimoto, Y [1 ]
机构
[1] Nihon Univ, Sch Dent, Dept Endodont, Chiba 2718587, Japan
关键词
ESR; hydroxyl radical; scavenging; L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effect of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-( 4,8,12- trimethyltridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt (EPC-K-1) on hydroxyl radical(. OH) elimination was studied using electron spin resonance (ESR) and spectrophotometric experiments. The addition of EFC-K-t and . OH scavengers eliminated the . OH generated from Cu2+/H2O2, Fe2+/H2O2 and H2O2/UV-irradiation reaction systems. However, in competitive reactions using different concentrations of a spin-trap agent, the addition of the . OH scavenger altered the IC50 values, whereas the addition of EPC-K-1 and a metal chelater did not change the value in the Cu2+/H2O2 and Fe2+/H2O2 reaction systems. The addition of EPC-K-1 and metal chelater changed the ESR signal for free Cu2+. The spectrophotometric experiments confirmed that the addition of EPC-K-1 and metal chelater altered the absorption spectra due to CuCl2 and FeSO4, whereas the . OH scavenger did nut alter the spectra. Therefore, it was demonstrated that EPC-K-1 has the ability both to scavenge . OH directly and to inhibit the generation of . OH by the chelation of Cu2+ and Fe2+.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 50 条
  • [11] SYNTHESIS AND ENANTIODIFFERENTIATION OF ISOMERIC 2,3,5,6,8,8A-HEXAHYDRO-2,5,5,8A-TETRAMETHYL-7H-1-BENZOPYRAN-7-ONES (3,4-DIHYDRO-3-OXOEDULANS)
    SCHMIDT, G
    NEUGEBAUER, W
    WINTERHALTER, P
    SCHREIER, P
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1995, 43 (07) : 1898 - 1902
  • [12] Optimization and synthesis of (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl)-1-propenyl]benzoic acid-11-[14C]
    Liu, SQ
    Berlin, KD
    Simms-Kelley, MD
    Nelson, EC
    Benbrook, DM
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1999, 42 (08): : 789 - 796
  • [13] 2-(1,3-Dioxo-4,5,6,7-tetrahydro-1H-isoindol-2-yl)-N-[7-fluoro-3-oxo-4-( prop-2-ynyl)-3,4-dihydro-2H-benzoxazin-6-yl]acetamide monohydrate
    Min, ZC
    Huang, MZ
    Chen, WM
    Zhang, Q
    Yang, GF
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 : O735 - O736
  • [14] Synthesis Characterization and Antimicrobial activity of 6 - oxido - 1 - ((5 -(4 - oxo - (2 - (pyridine - 3 - yl) thiazolidin - 3 - yl) 1,3,4 - thiadiazol - 2 - yl) methyl) - 4,8 - dihydro- 1H-[1,3,2] dioxaphosphepino [5,6-c] pyrazol - 6 - yl) carbamates
    Praveena, Lakshmi C. H.
    Rani, Esther, V
    Ravindranath, L. K.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (03): : 867 - 875
  • [15] 2-(4,5,6,7-tetrafluorobenzimidazol-2-yl)-4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazole-3-oxide-1-oxyl, a hydrogen-bonded organic quasi-1D ferromagnet
    Murata, Hidenori
    Miyazaki, Yuji
    Inaba, Akira
    Paduan-Filho, Armando
    Bindilatti, Valdir
    Oliveira, Nei Fernandes, Jr.
    Delen, Zeynep
    Lahti, Paul M.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (01) : 186 - 194
  • [16] 2-{4-[(E)-2,3-Diiodoallyl]-7-fluoro-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl}-2,3,4,5,6,7-hexahydro-1H-isoindole-1,3-dione
    Pang, Huai-Lin
    Huang, Yin
    Yin, Du-Lin
    Yang, Hai
    Li, Wen-An
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O2742 - U1665
  • [17] Neuroprotective effects of (S)-N-[4-[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an inhibitor of neuronal nitric-oxide synthase and an antioxidant, in model of transient focal cerebral ischemia in mice
    Zhou, LD
    Marchand-Verrecchia, C
    Palmier, B
    Croci, N
    Chabrier, PE
    Plotkine, M
    Margaill, I
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02): : 588 - 594
  • [18] Activity of 7,8-dihydro-isoquinoline-6-carboxylic acid [2-(1H-indol-3-yl)-ethyl]-amide hydrochloride salt against Human Cytomegalovirus (HCMV)
    Bedard, J
    Rando, R
    Chan, L
    Jin, H
    Andrei, RG
    Snoeck, R
    Daelemans, D
    De Clercq, E
    Neyts, J
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A60 - A60
  • [19] Synthesis and herbicidal activity of 2-(7-fluoro-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)isoindoline-1,3-diones
    Huang, MZ
    Huang, KL
    Ren, YG
    Lei, MX
    Huang, L
    Hou, ZK
    Liu, AP
    Ou, XM
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2005, 53 (20) : 7908 - 7914
  • [20] Preparation and pharmacological characterization of the enantiomers of the anticancer agent R / S- N-3-cyanophenyl- N '-(6-tert-butoxycarbonylamino-3,4-dihydro-2 , 2-dimethyl-2H-1-benzopyran-4-yl)urea: Identification of the R-enantiomer as the active eutomer
    Schnekenburger, Michael
    Goffin, Eric
    Schoumacher, Matthieu
    Tumanov, Nikolay
    Mouithys-Mickalad, Ange
    de Tullio, Pascal
    Wouters, Johan
    Lebrun, Philippe
    Diederich, Marc
    Pirotte, Bernard
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2025, 13